Navigation Links
Sugammadex in Medical News

Sugammadex Study First to Show Rapid Reversal of Profound Rocuronium-Induced Muscle Relaxation is Possible

... Publication of Comparative Study Shows sugammadex Provides Significantly Faster Reversal of Profound...sthesiology (Vol. 109, No. 5)(1) demonstrated that sugammadex produced a significantly more rapid recovery from ...the median time to recovery was 2.7 minutes in the sugammadex group versus 49.0 minutes in the neostigmine group...
Sugammadex in Medical Technology

U.S. FDA Issues Action Letter for Sugammadex

KENILWORTH, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) has issued a "not-approvable" letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia. ...

European Union's CHMP Issues Positive Opinion on Sugammadex

Anesthesiologists to have new tool that works within minutes, upon European approval KENILWORTH, N.J., June 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported that the Committee for Medicinal Products for Human Use (CHMP) of the Eu...

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine

OSS, the Netherlands, June 11, 2007-Sugammadex - the novel selective relaxant binding agent (SRBA) being developed by Organon, the human healthcare business unit of Akzo Nobel - demonstrated in a Phase III pivotal trial a 9-12 times faster reversal of neuromuscular blockade as compared to neostigmi...

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine

OSS, The Netherlands, June 11, 2007 /PRNewswire/ -- Sugammadex - the novel selective relaxant binding agent (SRBA) being developed by Organon, the human healthcare business unit of Akzo Nobel - demonstrated in a Phase III pivotal trial a 9-12 times faster reversal of neuromuscular blockade as comp...

Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)

...s recommended to monitor the recovery of neuromuscular blockade. The use of sugammadex in patients with severe renal impairment is not recommended. In clinical ...duals, allergic-like reactions (i.e. flushing, erythematous rash) following sugammadex were reported. For full Prescribing Information please go to http://www....

BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union

...(moderate block) patients were administered either sugammadex or neostigmine plus glycopyrrolate. In the AURORA ... a TOF ratio of 0.9 occurred in 1.4 minutes in the sugammadex group compared to 17.6 minutes in the neostigmine/... were randomized to receive either rocuronium plus sugammadex or the rapid-onset, short- duration muscle relaxan...

FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent

...decision on approval is made. Upon FDA approval, sugammadex will be the first and only selective relaxant bind...duced by rocuronium and vecuronium within minutes. sugammadex allows for flexible dosing of muscle relaxation ag...e used. We will continue to work with FDA to bring sugammadex to the U.S. market as soon as possible so that ane...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

... SAN FRANCISCO, Oct. 16 /PRNewswire/ -- sugammadex -- the novel selective relaxant binding agent (SRB...e Signal trial compared the efficacy and safety of sugammadex and neostigmine/glycopyrrolate for the reversal of...Spectrum trial compared the efficacy and safety of sugammadex for reversal of profound rocuronium-induced neurom...
Sugammadex in Biological Technology

Schering-Plough Announces Sugammadex New Drug Application Filed in Japan

KENILWORTH, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) announced that Nippon Organon K.K., now part of Schering-Plough, has filed a New Drug Application with the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking marketing approval for its nov...

Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA

KENILWORTH, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) has assigned priority review status to the company's New Drug Application (NDA) for sugammadex. Sugammadex is specifically designed to...

Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

...the U.S. Food and Drug Administration (FDA); and -- Filing regulatory submissions for important new agents and indications, which now include sugammadex and asenapine from Organon. "Schering-Plough now has four full years of accomplishments since we began this transformation," said Hassan. "In that t...

Schering-Plough Completes Acquisition of Organon BioSciences

...anon), an oral contraceptive; * ORG 50081 (from Organon), for the treatment of insomnia and potentially for hot flashes in menopausal women; * sugammadex (from Organon), for the reversal of neuromuscular blockade used as part of general anesthesia during surgical procedures; * Tablet-based subling...
Other Tags
(Date:8/29/2014)... Calif. (PRWEB) August 29, 2014 LiveOps, ... customer service solutions, today announced that LiveOps has been ... Dystrophy Association's (MDA) Show of Strength Telethon for the ... event raises money and awareness to support MDA’s mission ... an aggressive and sometimes fatal muscle disease. This year’s ...
(Date:8/29/2014)... HealthDay Reporter THURSDAY, ... of American babies are getting the vaccines they need ... said Thursday. More than 90 percent of children ... rubella (MMR); polio; hepatitis B and chickenpox (varicella), according ... "Nationally, vaccination among children 19 to 35 months ...
(Date:8/29/2014)... August 29, 2014 Floors of hospitals ... when wearing socks. Also, many patients are relegated to ... balance, surgery recovery, Alzheimer’s, etc. Two inventors from Perrysburg, ... optimize patient safety. , This special pair of socks ... also keeps patients who are relegated to beds or ...
(Date:8/29/2014)... (HealthDay News) -- Selling cigarettes in plain packages doesn,t ... doesn,t harm sales in small stores, according to new ... the tobacco industry when it tried to prevent Australia ... introduce plain packaging for tobacco products in 2012. Similar ... the U.K. Researchers surveyed nearly 2,000 adult smokers ...
(Date:8/29/2014)... 29, 2014 Honey Gifts, premium Vancouver ... will now be selling purse-sized adult toys and erotic ... that they can be carried in a woman’s purse ... purse-sized range at Honey Gifts is also leak-free and ... and rechargeable batteries are common characteristics of Honey Gifts’ ...
Breaking Medicine News(10 mins):Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2
(Date:8/29/2014)... modern materials that are light, flexible and highly conductive ... electronic paper. , Making such concepts affordable enough for ... of working with copper nanowires and a PVA "nano ... in the field of ultra-lightweight "aerogel monoliths" has largely ... nanowires. , By turning instead to copper, both ...
(Date:8/28/2014)... Yale University researchers have identified a handful of bacterial ... as Crohn,s disease and ulcerative colitis, using patients, own ... are published Aug. 28 in the journal Cell ... intestinal microbiota, which plays a critical role in the ... only a small number of bacterial species affect a ...
(Date:8/28/2014)... MD FASEB MARC (Maximizing Access to Research Careers) ... American Society of Human Genetics from October 18 ... are meant to promote the entry of students, post ... of the basic science community and to encourage the ... Human Genetics. This year MARC conferred 16 awards ...
Breaking Biology News(10 mins):Copper shines as flexible conductor 2Yale study identifies possible bacterial drivers of IBD 2
Other Contents